A series of 1-(di)halo-2-fluoroethanes reported in the literature to b
e nontoxic or of low toxicity were found to be highly toxic by the inh
alation route. Experiments were performed that showed the compounds, 1
,2-difluoroethane, 1-chloro-2-fluoroethane, 1-chloro-1,2-difluoroethan
e, and 1-bromo-2-fluoroethane to be highly toxic to rats upon inhalati
on for 4 hr. All four compounds had 4-hr approximate lethal concentrat
ions of less than or equal to 100 ppm in rats. In contrast, 1,1-difluo
roethane (commonly referred to as HFC-152a) has very low acute toxicit
y with a 4-hr LC50 of >400,000 ppm in rats. Rats exposed to the select
ed toxic fluoroethanes showed clinical signs of fluoroacetate toxicity
(lethargy, hunched posture, convulsions). 1,2-Diffuoroethane, 1-chlor
o-2-fluoroethane, 1-chloro-1,2-difluoroethane, and 1-bromo-2-fluoroeth
ane were shown to increase concentrations of citrate in serum and hear
t tissue, a hallmark of fluoroacetate intoxication. F-19 NMR analysis
confirmed that fluoroacetate was present in the urine of rats exposed
to each toxic compound. Fluorocitrate, a condensation product of fluor
oacetate and oxaloacetate, was identified in the kidney of rats expose
d to 1,2-difluoroethane. There was a concentration-related elevation o
f serum and heart citrate in rats exposed to 0-1000 ppm 1,2-difluoroet
hane. Serum citrate was increased up to 5-fold and heart citrate was i
ncreased up to Ii-fold over control citrate levels, Metabolism of 1,2-
diffuoroethane by cytochrome P450 (most likely CYP2E1) is suspected be
cause pretreatment of rats or mice with SKF-525A, disulfiram, or dimet
hyl sulfoxide prevented or delayed the toxicity observed in rats not p
retreated. Experimental evidence indicates that the metabolism of the
toxic fluoroethanes is initiated at the carbon-hydrogen bond, with met
abolism to fluoroacetate via an aldehyde or an acyl fluoride. The resu
lts of these studies show that 1-(di)halo-2-fluoroethanes are highly t
oxic to rats and should be considered a hazard to humans unless demons
trated otherwise. (C) 1996 Society of Toxicology